首页> 外文期刊>Pediatric Research >INCREASED AVAILABILITY OF PHOSPHORIBOSYL PYROPHOSPHATE AS THE BASIS FOR ENHANCED 6-MERCAPTOPURINE INCORPORATION BY METHOTREXATE, IN CULTURED HUMAN LYMPHOBLASTS: 52
【24h】

INCREASED AVAILABILITY OF PHOSPHORIBOSYL PYROPHOSPHATE AS THE BASIS FOR ENHANCED 6-MERCAPTOPURINE INCORPORATION BY METHOTREXATE, IN CULTURED HUMAN LYMPHOBLASTS: 52

机译:作为人类淋巴母细胞增强甲氨蝶呤增强6-巯基嘌呤掺入的基础,磷酸焦磷酸焦磷酸酯的利用率提高:52

获取原文
获取外文期刊封面目录资料

摘要

In this study we have examined the inhibition of purine de novo synthesis by methotrexate (MTX), with concommitant increase of intracellular PRPP concentrations and enhancement of 6-mercaptopurine (6MP) incorporation. We found a significant elevation of PRPP concentrations in three cultured human leukemic cell lines (Molt-4, Raji, KM3), treated with 0.2 μM and 0.02 μM MTX, respectively. The maximal increase of the intracellular PRPP concentrations occured after distinct time intervals, dependent on both the MTX concentration and the cell type used.During incubation with MTX, samples were taken at various time points and the cells were studied on the availability to incorporate [8-14 C] -6MP. Enhanced 6MP incorporation was observed in time after treatment. At the time points measured, the enhancement of 6MP incorporation correlated well with the increased PRPP levels.
机译:在这项研究中,我们研究了甲氨蝶呤(MTX)对嘌呤从头合成的抑制作用,同时伴随着细胞内PRPP浓度的增加和6-巯基嘌呤(6MP)掺入的增加。我们发现三种培养的人类白血病细胞系(Molt-4,Raji,KM3)中的PRPP浓度显着升高,分别用0.2μM和0.02μMMTX处理。细胞内PRPP浓度的最大增加发生在不同的时间间隔后,这取决于MTX浓度和所用细胞类型。与MTX孵育期间,在不同时间点采集样品,并研究了细胞掺入的可能性[8 -14 C] -6MP。在治疗后及时观察到增强的6MP结合。在测量的时间点,6MP掺入的增强与PRPP水平的增加有很好的相关性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号